health
Preprint finds ACER2 inhibitor KPB82 protects tumor cells from doxorubicin
A bioRxiv preprint reports that KPB82 selectively inhibits ACER2 and reduces doxorubicin-induced cytotoxicity in several cell models, including tumor-derived cells. The findings are from laboratory experiments, not studies in animals or patients.